We examined whether CB 1 receptors in smooth muscle conform to the signaling pattern observed with other G i-coupled receptors that stimulate contraction via two G␤␥-dependent pathways (PLC-␤3 and phosphatidylinositol 3-kinase/integrin-linked kinase). Here we show that the anticipated G␤␥-dependent signaling was abrogated. Except for inhibition of adenylyl cyclase via G␣ i, signaling resulted from G␤␥-independent phosphorylation of CB 1 receptors by GRK5, recruitment of ␤-arrestin1/2, and activation of ERK1/2 and Src kinase. Neither uncoupling of CB1 receptors from Gi by pertussis toxin (PTx) or Gi minigene nor expression of a G␤␥-scavenging peptide had any effect on ERK1/2 activity. The latter was abolished in muscle cells expressing ␤-arrestin1/2 siRNA. CB 1 receptor internalization and both ERK1/2 and Src kinase activities were abolished in cells expressing kinase-deficient GRK5(K215R). Activation of ERK1/2 and Src kinase endowed CB 1 receptors with the ability to inhibit concurrent contractile activity. We identified a consensus sequence ( 102 KSPSKLSP 109 ) for phosphorylation of RGS4 by ERK1/2 and showed that expression of a RGS4 mutant lacking Ser 103 /Ser 108 blocked the ability of anandamide to inhibit acetylcholine-mediated phosphoinositide hydrolysis or enhance G␣q:RGS4 association and inactivation of G␣q. Activation of Src kinase by anandamide enhanced both myosin phosphatase RhoA-interacting protein (M-RIP):RhoA and M-RIP:MYPT1 association and inhibited Rho kinase activity, leading to increase of myosin light chain (MLC) phosphatase activity and inhibition of sustained muscle contraction. Thus, unlike other Gi-coupled receptors in smooth muscle, CB1 receptors did not engage G␤␥ but signaled via GRK5/ ␤-arrestin activation of ERK1/2 and Src kinase: ERK1/2 accelerated inactivation of G␣q by RGS4, and Src kinase enhanced MLC phosphatase activity, leading to inhibition of ACh-stimulated contraction. beta arrestin; CB1 receptors; ERK1/2; GRK5; Src kinase THE PROPERTIES AND ROLE OF G protein-coupled cannabinoid receptors, CB 1 and CB 2 , have been extensively studied in their primary locations: the central and peripheral nervous system and the immune system, respectively (3, 8, 22, 32) . The location of CB 1 receptors in the brain (cerebral cortex, hippocampus, basal ganglia, amygdala, and cerebellum) correlates with the observed psychotropic effects of cannabinoids. It is increasingly evident, however, that CB 1 receptors and the endocannabinoid system that provides them with lipid ligands on demand are more widely distributed, though less abundantly than in neural tissue. Thus CB 1 receptors are expressed in both vascular and visceral smooth muscle [e.g., cerebral arterial smooth muscle (7), vas deferens (5), and myometrial smooth muscle (2)], where they signal variously via G␣ i -dependent inhibition of adenylyl cyclase and G␤␥-dependent inhibition of voltage-gated L-type Ca 2ϩ channels, and activation of various kinases [phosphatidylinositol 3-kinase (PI 3-kinase), extracellular signal-regulated kinase (ERK1/2), and Src kinase].
smooth muscle (7) , vas deferens (5) , and myometrial smooth muscle (2) ], where they signal variously via G␣ i -dependent inhibition of adenylyl cyclase and G␤␥-dependent inhibition of voltage-gated L-type Ca 2ϩ channels, and activation of various kinases [phosphatidylinositol 3-kinase (PI 3-kinase), extracellular signal-regulated kinase (ERK1/2), and Src kinase].
In the present study, we examined signaling by G i -coupled CB 1 receptors in gastric smooth muscle cells, a model system used extensively to examine signaling by G protein-coupled receptors (16, 20) . Earlier studies had shown that receptors coupled to G i1 (e.g., opioid , ␦, ) (19) , G i2 (e.g., somatostatin sstr3) (17) , or G i3 (e.g., adenosine A 1 ) (18) induce contraction by activating dual pathways initiated by G␤␥: the first involves activation of PLC-␤3, stimulation of IP 3 -dependent Ca 2ϩ release, and phosphorylation of myosin light chain (MLC) 20 (MLC 20 ) by Ca 2ϩ /calmodulin-dependent MLC kinase, resulting in a transient initial muscle contraction. The second pathway involves sequential activation of PI 3-kinase and integrinlinked kinase: the latter acts as a Ca 2ϩ -independent MLC kinase and inhibits MLC phosphatase by activating CPI-17 (PKC-potentiated inhibitor 17-kDa protein), an endogenous inhibitor of the catalytic PP1c␦ subunit of MLC phosphatase (10) . The dual effects of integrin-linked kinase result in sustained MLC 20 phosphorylation and muscle contraction. We wondered whether CB 1 receptors would conform to the stimulatory pattern of signaling observed with other G i -coupled receptors or trigger pathways that attenuate smooth muscle contraction, consistent with the inhibitory effect of CB 1 receptors in other locations. Here we show that the expected activation of G␤␥-dependent pathways that lead to stimulation of contraction was abrogated. Except for inhibition of adenylyl cyclase via G␣ i , signaling resulted from G␤␥-independent phosphorylation of CB 1 receptors by GRK5, binding of ␤-arrestin to the phosphorylated receptors, and activation of ERK1/2 and Src kinase (26) . Both ERK1/2 and Src kinase inhibited concurrent contraction stimulated by acetylcholine (ACh) by targeting specific steps in the pathways that mediate contraction: ERK1/2 via phosphorylation of RGS4 (regulator of G protein signaling) and rapid inactivation of G␣ q .GTP, and Src kinase via enhanced association of RhoA and MYPT1 (myosin phosphatase targeting subunit) with M-RIP (myosin phosphatase RhoA-interacting protein), leading to increase in MLC phosphatase activity. Experimental animals. New Zealand White rabbits (weight: 4 -5 lbs) were purchased from RSI Biotechnology, Clemmons, NC. The rabbits were housed in the animal facility administered by the Division of Animal Resources, Virginia Commonwealth University, and maintained in a temperature-controlled environment with free access to food and water. The rabbits were euthanized by injection of Euthasol overdose (100 mg/kg); this and all other procedures were approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth University.
MATERIALS AND METHODS

Reagents. N-arachidonylethanolamine
Preparation of dispersed and cultured smooth muscle cells. Smooth muscle cells were isolated from strips of circular muscle layer of rabbit stomach by sequential enzymatic digestion, filtration, and centrifugation as described in detail previously (17) (18) (19) . Freshly dispersed muscle cells were suspended in a medium consisting of 120 mM NaCl, 4 mM KCl, 2.6 mM KH 2PO4, 2 mM CaCl2, 0.6 mM MgCl 2, 25 mM HEPES, 14 mM glucose, and 2.1% Eagle's essential amino acid mixture (pH 7.4). In some experiments, smooth muscle cells were cultured in DMEM containing 10% fetal bovine serum until they attained confluence; the cells were redispersed and passaged once for use in various studies (20) .
Detection of cannabinoid receptor expression by PCR. Total RNA was extracted from cultured gastric smooth muscle cells by treatment with RNaqueous reagent and contaminant genomic DNA removed by treatment with TURBO DNase as described previously (23) . RNA (5 g) was reversibly transcribed and amplified by PCR under standard conditions. Specific primers for rabbit CB 1 and CB2 receptors were designed based on identical sequences in human, rat, and mouse cDNA. CB1: forward 5=ACATGGCATCCAAATTAGG3= reverse 5=CAGTTTGAA-CAGAAACAC3=; CB2: forward 5=AGCTGACTTCCTGGCCAG3= reverse 5=AGTCTTGGCCAACCTCAC3=. PCR products were purified and sequenced.
Detection of cannabinoid receptors by Western blot. The expression of CB 1 or CB2 receptors was determined by Western blot as described previously (23) by using homogenates prepared from freshly dispersed gastric smooth muscle cells. Proteins were resolved by 15% SDS-PAGE and electrophoretically transferred to nitrocellulose membranes. The membranes were incubated for 12 h at 4°C with Bound and free radioligands were separated by rapid filtration through 5-m polycarbonate nucleopore filters followed by washing with HEPES medium. Nonspecific binding (26 Ϯ 5%) was determined as the amount of radioactivity associated with the muscle cells in the presence of 1 M AEA.
Identification of G proteins coupled to CB 1 receptors. G proteins activated by AEA were identified by an adaptation of the method of Okamoto et al. (21, 34) as described previously. Homogenates of dispersed muscle cells were centrifuged at 30,000 g for 30 min at 4°C, and the membranes solubilized at 4°C in 20 mM HEPES (pH 7.4) buffer. Solubilized membranes were incubated for 20 min at 37°C with 100 nM [
35 S]GTP␥S in 10 mM HEPES in the presence or absence of 1 M AEA. The reaction was stopped and the membranes were reincubated for 2 h on ice in wells precoated with specific antibodies to G␣ s, G␣q, G␣i1, G␣i2, and G␣i3. Radioactivity from each well was counted by liquid scintillation.
Transfection of GRK2, GRK5, and RGS4 mutants and ␤-arrestin1 and -2 siRNA into cultured smooth muscle cells. Wild-type GRK2, GRK5, RGS4, kinase-deficient GRK2(K220R) and GRK5(K215R), phosphorylation-deficient RGS4(S103A/S108A), and ␤-arrestin1 and -2 siRNA were subcloned into the multiple cloning site (EcoRI) of the eukaryotic expression vector pcDNA3. Recombinant plasmid cDNAs were transiently transfected into smooth muscle cultures for 48 h. The cells were cotransfected with 2 g pcDNA3 vector and 1 g of pGreen Lantern-1 DNA to monitor transfection efficiency (23) .
Cannabinoid receptor phosphorylation. Phosphorylation of CB 1 receptor was determined from the amount of 32 P incorporated after immunoprecipitation with specific antibody for CB1 receptor. Cultured muscle cells were transfected with control vector or vector containing kinase-deficient GRK5(K215R) in wells containing 2 ϫ 10 6 cells and labeled with 0.5 Ci/ml of [ 32 P]orthophosphate for 3 h. The cells were then treated with or without 1 M AEA for 15 min. The reaction was terminated with an equal volume of lysis buffer (final concentrations: 1% Triton X-100, 0.5% SDS, 0.75% deoxycholate, 10 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 100 g/ml aprotinin, 10 mM Na 2P2O7, 50 mM NaF, 0.2 mM Na3VO4) and placed on ice for 30 min. Cell lysates were separated by centrifugation at 13,000 rpm for 15 min at 4°C. The lysates were incubated with CB1 receptor antibody for 2 h at room temperature, and then overnight at 4°C after addition of 25 l of Protein A/G plus agarose. The immunoprecipitates were washed with lysis buffer, extracted by boiling with Laemmli buffer for 15 min, and separated by SDS gel electrophoresis.
32 P-labeled CB1 receptor was visualized by autoradiography (15) . Assay of PI hydrolysis. Phosphoinositide (PI) hydrolysis was measured by anion exchange chromatography and expressed as total inositol phosphate formation as described previously (34) . Freshly dispersed muscle cells (10 6 cells/ml) were labeled with myo-[ 3 H] inositol (0.5 Ci/ml) for 3 h, then centrifuged at 350 g for 10 min and resuspended in 10 ml fresh HEPES medium. Cell aliquots (2 ϫ 10 6 cells/ml) were treated with ACh for 60 s in the presence or absence of 1 M AEA. In other studies, muscle cells were cultured in wells ( I-cAMP. Cells (3ϫ10 cells) were treated with AEA for 60 s in the presence of 100 m isobutylmethylxanthine 1-methyl-3-isobutylxanthine or 3,7-dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione (IBMX), and the reaction was terminated with 10% trichloroacetic acid. The samples were acetylated with triethylamine/acetic anhydride (2:1) for 30 min and cAMP was measured in duplicate by using 100-l aliquots. The results were expressed as picomoles per milligram protein.
Measurement of [Ca 2ϩ ]i in cultured smooth muscle cells. Dispersed muscle cells were plated on coverslips for 12 h in DMEM. The cells were washed and loaded with 10 M fura 2-AM in HEPES medium. [Ca 2ϩ ]i was measured by fluorescence in single smooth muscle cells loaded with the fluorescent Ca 2ϩ dye fura 2-AM as previously described (11) . The cells were alternately excited at 380 and 340 nm and imaged at 15-s intervals. The emitted light was imaged at 510 nm. Background and autofluorescence were corrected from images of unloaded control cells.
Measurement of contraction in dispersed smooth muscle cells. Muscle cell contraction was measured in freshly dispersed muscle cells by scanning microscopy as described previously (11, 34) . Cell aliquots containing ϳ10 4 muscle cells/ml were treated with 1 M AEA and 0.1 M ACh for different time periods (30 s to 10 min), and the reaction was terminated with 1% acrolein. The lengths of treated muscle cells were compared with the lengths of untreated cells, and contraction was expressed as the percent decrease in cell length from control.
Statistical analysis. The results were expressed as means Ϯ SE of n experiments and analyzed for statistical significance by Student's t-test for paired and unpaired values. Differences among groups were tested by ANOVA and checked for significance via Fisher's protected least significant difference test. P Ͻ 0.05 was considered significant.
RESULTS
Selective expression of CB 1 receptors in smooth muscle cells. CB 1 receptors were detected by RT-PCR and Western blot in cultured rabbit gastric smooth muscle cells and in brain homogenates, whereas CB 2 receptors were detected in spleen homogenates but not in cultured smooth muscle cells (Fig. 1A) . The partial amino acid sequence of rabbit CB 1 receptors was closely similar to the corresponding amino acid sequences of human (96%), rat (96%), and mouse (97%). Binding of [ 3 H]CP55,940 to dispersed smooth muscle cells was inhibited by AEA in a concentration-dependent fashion (IC 50 5 nM), consistent with expression of CB 1 receptors in these cells (Fig. 1B) . (Fig. 1C) . The results implied that CB 1 receptors are preferentially coupled to G␣ i2 .
Consistent with the coupling of CB 1 receptors to G␣ i1-3 , AEA inhibited forskolin-stimulated cAMP formation in dispersed muscle cells in a concentration-dependent fashion (IC 50 13 nM) (Fig. 2A) . The inhibition was blocked by the CB 1 receptor antagonist AM251 and by preincubation of the muscle cells for 60 min with 400 ng/ml of PTx. By itself, AEA had no effect on basal cAMP formation, and AM251, which can act as a reverse agonist in some cells (6, 27) , had no effect on basal or forskolin-stimulated cAMP formation in smooth muscle cells (Fig. 2B) . AEA inhibited forskolin-stimulated cAMP formation in cultured muscle cells also; the inhibition was blocked in cells expressing G␣ i minigene (Fig. 2C ). Our previous studies had shown that G␣ i minigenes selectively block responses mediated by G␣ i (34) .
Absence of G␤␥-dependent stimulation of PI hydrolysis and muscle contraction by CB 1 receptor agonist.
Receptors coupled to G i1-3 stimulate PI hydrolysis and smooth muscle contraction via G␤␥-dependent activation of PLC-␤3 (17) (18) (19) . Activation of CB 1 receptors with AEA, however, did not stimulate PI hydrolysis or induce muscle contraction (Figs. 3,  A and B) . In contrast, as shown previously (18, 19) and confirmed in this study, activation of G i3 -coupled adenosine A 1 receptors with CPA and G i2 -coupled ␦-opioid receptors with DPDPE stimulated PI hydrolysis and induced muscle contraction (Figs. 3, A and B) . The results implied that CB 1 (Fig. 4A) . (Fig. 4B) . Expression of kinase-deficient GRK5(K215R) blocked CB 1 receptor internalization whereas expression of kinase-deficient GRK2(K220R) had no effect, suggesting that CB 1 receptor internalization was dependent on receptor phosphorylation by GRK5 and not by GRK2/3 (9, 11) (Fig. 4B) .
ERK1/2 and Src kinase activation by CB 1 receptors depends on receptor phosphorylation and activation of ␤-arrestin1/2. Treatment of cultured smooth muscle cells with AEA stimulated ERK1/2 activity in a time-dependent fashion; ERK1/2 activity was blocked by AM251 (Fig. 5A) . The increase in ERK1/2 activity was significant within 1 min and attained a sustained maximum within 10 min (Fig. 5A ). ERK1/2 activity was abolished by the ERK1/2 inhibitor PD98059 but was not affected by the PKC inhibitor bisindolylmaleimide or PTx or in cells expressing a G i minigene, implying that it was not dependent on activation of G␣ i (Fig. 5B ). ERK1/2 activity was not affected also in cells expressing the COOH-terminal sequence of GRK2 [GRK2CT(495-689)], which competes with cytosolic GRK2 for binding to G␤␥ (Fig. 5B) , or in cells expressing kinase-deficient GRK2(K220R) (Fig. 5C ), implying that ERK1/2 activity was not dependent on recruitment of GRK2 to the receptor by G␤␥ or receptor phosphorylation by GRK2. ERK1/2 activity was blocked, however, in cells expressing kinase-deficient GRK5(K215R) (Fig. 5C ) and in cells expressing siRNA for ␤-arrestin1 and 2 (Fig. 5D ), implying that ERK1/2 activation resulted from AEA-induced phosphorylation of CB 1 receptors by GRK5 and binding of ␤-arrestin1/2 to phosphorylated CB 1 receptors.
In similar fashion, treatment of cultured muscle cells with AEA for 5 min stimulated Src kinase activity. Activation of Src kinase was blocked by PP2 and AM251 (Fig. 6A) , and in cells expressing GRK5(K215R) (Fig. 6B ), but not in cells expressing GRK2CT(495-689). Thus Src kinase activation also resulted from AEA-induced phosphorylation of CB 1 receptors via G␤␥-independent GRK5 and the binding of ␤-arrestin to phosphorylated CB 1 receptors.
Activation of ERK1/2 and Src kinase modulates ACh-stimulated contraction via phosphorylation of RGS4 by ERK1/2 and M-RIP and MYPT1 by Src kinase. Activation of ERK1/2
and Src kinase raised the possibility that one or both kinases could modulate concurrent smooth muscle contraction. As shown previously (20) and confirmed in the present study, ACh acting via m3 receptors (i.e., ACh in the presence of the m2 receptor antagonist methoctramine) stimulates PI hydrolysis and induces a biphasic contraction consisting of an initial 30 s peak followed by a sustained contraction. AEA inhibited both initial and sustained ACh-stimulated contraction (Fig. 7A) . AEA inhibited ACh-stimulated PI hydrolysis, [Ca 2ϩ ] i , and initial contraction in dispersed smooth muscle cells by 65 Ϯ 6% (P Ͻ 0.01), 66 Ϯ 13% (P Ͻ 0.01), and 54 Ϯ 2% (P Ͻ 0.001), respectively: the inhibition of PI hydrolysis and initial contraction was selectively blocked by PD98059, but not by bisindolylmaleimide or PP2 (Figs. 7, B and C) , implying that it was mediated by ERK1/2.
We next examined the mechanism by which ERK1/2 inhibited PI hydrolysis and muscle contraction. ACh-stimulated PI hydrolysis in smooth muscle is mediated by G␣ q -dependent activation of PLC-␤1 and regulated by RGS4, which binds to and enhances the intrinsic GTPase activity of G␣ q .GTP (12) . We identified a proline-rich consensus site ( 102 KSPSKLSP 109 ) in RGS4 for phosphorylation by ERK1/2 and hypothesized that phosphorylation of Ser 103 and/or Ser 108 by ERK1/2 could further enhance the GTPase activity of G␣ q .GTP leading to rapid inactivation of G␣ q and inhibition of G␣ q -dependent PI hydrolysis. In control cultured muscle cells, AEA inhibited ACh-stimulated PI hydrolysis and increased G␣ q :RGS4 association, whereas in cultured muscle cells expressing a mutant RGS4(S103A/S108A) that lacks ERK1/2 phosphorylation sites, AEA did not inhibit PI hydrolysis or increase G␣ q :RGS4 association (Fig. 7D) . The results suggest that inhibition of PI hydrolysis and initial muscle contraction by AEA-stimulated ERK1/2 is mediated via stimulatory phosphorylation of RGS4, resulting in rapid inactivation of G␣ q .GTP.
Unlike initial contraction, sustained contraction is mediated by Rho kinase-dependent phosphorylation of MYPT1 and inhibition of MLC phosphatase activity (16, 20) . Measurements of sustained contraction and Rho kinase activity were, therefore, made 5 min after treatment with ACh and AEA. AEA inhibited ACh-stimulated Rho kinase activity and sustained contraction in dispersed muscle cells by 48 Ϯ 8 and 48 Ϯ 5%, respectively; P Ͻ 0.01 (Fig. 8, A and B) . Inhibition of sustained contraction and Rho kinase activity was blocked by AM251 and PP2, but not by PD98059 (Fig. 8, A and B) .
As previously shown (16, 20, 30) , the decrease in Rho kinase activity should lead to decrease in MYPT1 phosphorylation by Rho kinase and thus enhance MLC phosphatase activity.
We hypothesized that Src kinase enhances the association of M-RIP (MYPT1/RhoA interacting protein) (13, 24) with both RhoA and MYPT1 leading to increase in MLC phosphatase activity (16, 20) . Treatment of cultured muscle cells with AEA for 10 min enhanced association of M-RIP with RhoA (Fig.  9A) and MYPT1 (Fig. 9B) . The increase in M-RIP:RhoA and M-RIP:MYPT1 association was blocked by AM251 and PP2 (Fig. 9, A and B) , and in smooth muscle cells expressing kinase-deficient GRK5(K215R) (Fig. 10, A and B) . Thus activation of Src kinase upon phosphorylation of CB 1 receptors by GRK5 enhanced the association of M-RIP with both RhoA and MYPT1. The increase in M-RIP:RhoA association inhibited Rho kinase activity and thus should inhibit Rho kinase-dependent MYPT1 phosphorylation, leading to increase in MLC phosphatase activity. The increase in M-RIP:MYPT1 association should enhance further the activity of the MLC phosphatase holoenzyme by fostering its binding to the actomyosin complex (13) . Both mechanisms result in inhibition of sustained muscle contraction.
DISCUSSION
The present study shows that CB 1 receptors are selectively expressed in smooth muscle cells and signal via G␣ i2 , causing inhibition of adenylyl cyclase activity, but do not signal via G␤␥ as do other G i -coupled receptors in these cells (17) (18) (19) . CB 1 receptors signal also via ␤-arrestin1/2 in a G proteinindependent fashion to activate ERK1/2 and Src kinase. Uncoupling of CB 1 receptors from G i by PTx or by expression of G i minigene abolished inhibition of cAMP but had no effect on ERK1/2 activity, whereas expression of kinase-deficient GRK5(K215R) or silencing of ␤-arrestin1/2 with siRNA abolished ERK1/2.
AEA-induced CB 1 receptor phosphorylation was blocked in smooth muscle cells expressing kinase-deficient GRK5 [GRK5(K215R)], implying that CB 1 receptors were phosphorylated by GRK5. Unlike GRK2/3, which are located in the cytosol and are recruited to G protein-coupled receptors by activated G␤␥ (9, 11), GRK5 and GRK6 are constitutively tethered to the plasma membrane, where they directly phosphorylate agonist-bound receptors (4). Activation of ERK1/2, which was significant within 1 min and maximal within 10 min, was not affected by expression of kinase-deficient GRK2(K220R) or a G␤␥-scavenging peptide, implying that it was not dependent on activation of G␤␥ or recruitment of GRK2. ERK1/2 activity was blocked, however, by expression of kinase-deficient GRK5(K215R) or ␤-arrestin1/2 siRNA, implying that ERK1/2 activation resulted from agonist-induced phosphorylation of CB 1 receptors by GRK5 and binding of ␤-arrestin1/2 to phosphorylated CB 1 receptors.
GRK5-dependent activation of ERK1/2 and Src kinase endowed CB 1 receptors with the ability to inhibit concurrent contractile activity. We had previously shown that the initial transient contraction induced by ACh is mediated by G␣ qdependent activation of PLC-␤1 and terminated by RGS4 (9, 11) . In this study, we identified a consensus sequence ( 102 KSP-SKLSP 109 ) for phosphorylation of RGS4 by ERK1/2 and showed that expression of a phosphorylation-deficient RGS4 mutant lacking Ser 103 and Ser 108 blocked the ability of AEA to inhibit of ACh-stimulated PI hydrolysis or enhance G␣ q :RGS4 association. Huang et al. (12) had previously reported a similar mechanism involving phosphorylation of RGS4 at Ser 52 by cyclic AMP-and cGMP-dependent protein kinases that resulted in inhibition of ACh-stimulated initial contraction and PI hydrolysis (12) .
Unlike the initial transient contraction, sustained contraction is mediated in part by Rho kinase-dependent phosphorylation of the myosin phosphatase-targeting subunit, MYPT1 (16, 29, and increases its association with and activation of G␣q-GTPase, resulting in inhibition of the G␣q/ PLC-␤/IP3/Ca 2ϩ /MLCK pathway that mediates initial contraction. Activation of Src kinase stimulates 1) M-RIP:MYPT1 association enhancing the ability of MYPT1 to activate MLC phosphatase, and 2) M-RIP:RhoA association, causing inhibition of Rho kinase and decreasing its ability to phosphorylate and inhibit MYPT1. Thus Src kinase acting via M-RIP enhanced MLCP activity, leading to inhibition of the G␣13/RhoA/Rho kinase/MYPT1/MLCP pathway that mediates sustained contraction.
31). Phosphorylation of MYPT1 at Thr
696 by Rho kinase inhibits the activity of the catalytic subunit of MLC phosphatase and fosters sustained MLC 20 phosphorylation and contraction. Stimulation of Src kinase activity by AEA enhanced both M-RIP:RhoA and M-RIP:MYPT1 association. The increase in M-RIP:RhoA association inhibited Rho kinase activity and, therefore, should attenuate MYPT1 phosphorylation by Rho kinase, leading to increase in MLC phosphatase activity, whereas the increase in M-RIP:MYPT1 association should enhance further the ability of MYPT1 to activate MLC phosphatase holoenzyme by fostering its binding to the actomyosin complex. The dual mechanism initiated by Src kinase upon phosphorylation of CB 1 receptors increased MLC phosphatase activity and inhibited sustained contraction (Fig. 11) .
The results of this study may be usefully compared with those of Shenoy et al. (25) obtained in cell lines expressing a ␤2 adrenergic receptor mutant (␤2AR TYY ) incapable of G protein activation. Overexpression of GRK5 or -6 in these cells enhanced recruitment of ␤-arrestin to the receptor and its ability to induce prompt, sustained activation of ERK1/2. GRK2 expression was effective only when targeted to the membrane by coexpression of a prenylation signal (CAAX). In our study, CB 1 receptors constitutively expressed in a native smooth muscle cell, signaled concurrently via G␣ i and ␤-arrestin, the latter upon receptor phosphorylation by GRK5. Uncoupling CB 1 receptors from G proteins by PTx or expression of G i minigene had no effect on ␤-arrestin-dependent activation of ERK1/2 and Src kinase. Unlike other G i -coupled receptors in smooth muscle, CB 1 receptors did not engage G␤␥ to initiate signaling that would have resulted in activation of dual pathways involving PLC-␤3 and PI 3-kinase/integrin linked kinase (17) (18) (19) .
The present study does not resolve the fate or role of G␤␥ in CB 1 receptor signaling. It is possible that interaction of G␤␥ with both CB 1 receptor and G␣ i allows for productive guanine nucleotide exchange on G␣ i without sustaining downstream signaling via G␤␥. Alternatively, the G␤␥ dimer could be atypical, consisting, for example, of G␤ 5 bound to the G␥-like domain of R7 subfamily of RGS proteins (e.g., RGS6, -7, -9, -11) (1, 28) . This subfamily is defined by the presence of three domains: an NH 2 -terminal DEP (Dishevelled, Egl, Pleckstrin) domain, linked via a DEP helical extension to a central G␥-like domain tightly bound to a COOH-terminal catalytic domain with selectivity for G␣ i . Although these atypical G protein dimers are preferentially expressed in neural tissues (28) , a member of this subfamily, G␤ 5 -RGS6, has also been found in smooth muscle (14) . A G␤ 5 -RGS6 heterodimer could bind to G␣ i and permit CB 1 receptor-mediated nucleotide exchange without being able to substitute for, or signal in place of, a canonical G␤␥. This intriguing notion, however, remains speculative.
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